Kim Henriksen

12.1k citations

201 papers · 9.0k indexed · h-index 55

Molecular Biology top 1%
Rheumatology top 0.2%
Oncology top 1%
Orthopedics and Sports Medicine top 0.5%
Physiology top 2%

Co-authors: M.A. Karsdal Claus Christiansen Anne‐Christine Bay‐Jensen Jens Bollerslev Per Qvist A.V. Neutzsky-Wulff Jean‐Marie Delaissé Morten Hanefeld Dziegiel
Topics: Bone Metabolism and Diseases (73 papers)Bone health and treatments (44 papers)Bone health and osteoporosis research (34 papers)
Cited by: Orthopedics and Sports Medicine Rheumatology Oncology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaThe Journal of Cell Biology
Partner nations: Denmark United States Germany

In The Last Decade

Kim Henriksen

197 papers receiving 8.8k citations

Peers

Countries citing papers authored by Kim Henriksen

Since Specialization

Citations

This map shows the geographic impact of Kim Henriksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Henriksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Henriksen more than expected).

Fields of papers citing papers by Kim Henriksen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Henriksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Henriksen. The network helps show where Kim Henriksen may publish in the future.

Co-authorship network of co-authors of Kim Henriksen

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Henriksen. A scholar is included among the top collaborators of Kim Henriksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Henriksen. Kim Henriksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight 2024 ·British Journal of Pharmacology ·(unknown),(unknown),M.A. Karsdal,Kim Henriksen	3
2	Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin 2022 ·European Journal of Pharmacology ·(unknown),(unknown),M.A. Karsdal,Kim Henriksen	9
3	Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD 2021 ·Alzheimer s Research & Therapy ·Everard G.B. Vijverberg,(unknown),Asger Reinstrup Bihlet,Kim Henriksen,Frank Weber,Katharina Fuchs,John Harrison,Kerstin Kühn‐Wache,Peter Alexandersen,Niels D. Prins,Philip Scheltens	27
4	Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases 2020 ·Molecular Metabolism ·(unknown),M.A. Karsdal,Kim Henriksen	39
5	Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serum 2017 ·Neurochemistry International ·Jesper Skov Neergaard,(unknown),Claus Christiansen,Henning B. Nielsen,Christopher T. Workman,Susanne Brix,Kim Henriksen,M.A. Karsdal	2
6	Bone marrow lesions are associated with pain, but not with inflammatory biomarkers in end-stage knee osteoarthritis patients 2017 ·Osteoarthritis and Cartilage ·Maja R Radojčić,Christian S. Thudium,Kim Henriksen,(unknown),Rolf Karlsten,(unknown),Iain P. Chessell,M.A. Karsdal,Anne‐Christine Bay‐Jensen,M.D. Crema,Ali Guermazi	1
7	Effect of Naproxen and KBP-056 in a collagen induced arthritis rat model of arthritic pain 2017 ·Osteoarthritis and Cartilage ·(unknown),(unknown),M.A. Karsdal,Christian S. Thudium,Kim Henriksen	1
8	Late-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women 2016 ·Medicine ·Jesper Skov Neergaard,(unknown),Henrik B. Hansen,Kim Henriksen,Claus Christiansen,M.A. Karsdal	31
9	Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta‐cell area and function in Zucker diabetic fatty rats 2012 ·British Journal of Pharmacology ·Michael Feigh,(unknown),A.V. Neutzsky-Wulff,(unknown),(unknown),Anne‐Christine Bay‐Jensen,Jan Erik Henriksen,Henning Beck‐Nielsen,Claus Christiansen,Kim Henriksen,M.A. Karsdal	23
10	The Pathogenesis of Osteoarthritis Involves Bone, Cartilage and Synovial Inflammation: May Estrogen Be a Magic Bullet? 2012 ·Menopause international ·M.A. Karsdal,Anne‐Christine Bay‐Jensen,Kim Henriksen,Claus Christiansen	36
11	Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue Diseases Possibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure 2012 ·Assay and Drug Development Technologies ·M.A. Karsdal,Mette Juul Nielsen,Jannie Marie Bülow Sand,Kim Henriksen,Federica Genovese,Anne‐Christine Bay‐Jensen,Victoria Smith,Joanne I. Adamkewicz,Claus Christiansen,Diana Julie Leeming	206
12	Tumor Necrosis Factor-Alpha and Receptor Activator of Nuclear Factor-κB Ligand Augment Human Macrophage Foam-Cell Destruction of Extracellular Matrix Through Protease-Mediated Processes 2011 ·Assay and Drug Development Technologies ·Helene Skjøt‐Arkil,Natasha Barascuk,Lise Larsen,Morten Hanefeld Dziegiel,Kim Henriksen,M.A. Karsdal	5
13	Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities 2011 ·Arthritis Research & Therapy ·M.A. Karsdal,Thasia Woodworth,Kim Henriksen,Walter P. Maksymowych,Harry K. Genant,Philippe Vergnaud,Claus Christiansen,(unknown),Per Qvist,Georg Schett,Adam Platt,Anne‐Christine Bay‐Jensen	90
14	A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet‐induced obese rats 2011 ·Diabetes Obesity and Metabolism ·Michael Feigh,Kim Henriksen,Kim Vietz Andreassen,(unknown),Jan Erik Henriksen,Henning Beck‐Nielsen,Claus Christiansen,M.A. Karsdal	38
15	Oral salmon calcitonin – pharmacology in osteoporosis 2010 ·Expert Opinion on Biological Therapy ·Kim Henriksen,Anne‐Christine Bay‐Jensen,Claus Christiansen,M.A. Karsdal	41
16	Should biochemical markers of bone turnover be considered standard practice for safety pharmacology? 2009 ·Biomarkers ·Kim Henriksen,Kurt M. Bohren,Anne‐Christine Bay‐Jensen,M.A. Karsdal	10
17	Estrogen Directly Attenuates Human Osteoclastogenesis, But Has No Effect on Resorption by Mature Osteoclasts 2006 ·DNA and Cell Biology ·Mette G Sørensen,Kim Henriksen,Morten Hanefeld Dziegiel,László B. Tankó,M.A. Karsdal	32
18	In Vitro, Ex Vivo , and In Vivo Methodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers Can Assist? 2005 ·Assay and Drug Development Technologies ·Sophie Schaller,Kim Henriksen,Pernille Høegh-Andersen,B.C. Søndergaard,E.U. Sumer,László B. Tankó,Per Qvist,M.A. Karsdal	93
19	A2 GADD45β is novel mediator of MMP-13 gene expression during chondrocyte hypertrophy 2005 ·Osteoarthritis and Cartilage ·B.C. Søndergaard,Kim Henriksen,(unknown),Søren Østergaard,Per Qvist,Yu Z. Bagger,Claus Christiansen,(unknown),M.A. Karsdal,Kosei Ijiri,Luiz F. Zerbini,Haibing Peng,Nicole C. Walsh,Xiaogang Huang,Hasan H. Otu,Binfeng Lu,Towia A. Libermann,Mary B. Goldring	1
20	Acidification of the Osteoclastic Resorption Compartment Provides Insight into the Coupling of Bone Formation to Bone Resorption 2005 ·American Journal Of Pathology ·M.A. Karsdal,Kim Henriksen,Mette G Sørensen,Jeppe Gram,Sophie Schaller,Morten Hanefeld Dziegiel,Anne‐Marie Heegaard,Palle Christophersen,T. John Martin,Claus Christiansen,Jens Bollerslev	130

About Kim Henriksen

Kim Henriksen is a scholar working on Orthopedics and Sports Medicine, Rheumatology and Immunology and Allergy, having authored 201 papers that have together received 9.0k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (73 papers), Bone health and treatments (44 papers) and Bone health and osteoporosis research (34 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.3k citations), Rheumatology (2.3k citations) and Oncology (2.2k citations). Kim Henriksen has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include M.A. Karsdal, Claus Christiansen, Anne‐Christine Bay‐Jensen, Jens Bollerslev, Per Qvist, A.V. Neutzsky-Wulff, Jean‐Marie Delaissé, Morten Hanefeld Dziegiel, Michael T. Engsig and Diana Julie Leeming. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact